Article
Washington - Although physicians, pharmaceutical manufacturers, and hospital officials have met with the FDA to discuss shortages of several anesthetics and other drugs, the federal agency has no plans to have a public hearing on the situation, according to an FDA spokesperson.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.